Numerous epidemiological, clinical, and animal studies showed that cardiac function and
manifestation of cardiovascular diseases (CVDs) are different between males and females …

The G Protein-Coupled Estrogen Receptor (GPER) is a novel membrane-bound receptor
that mediates non-genomic actions of the primary female sex hormone 17β-estradiol …

Context The effect of kaempferol, a regulator of oestrogen receptors, on atherosclerosis (AS)
and the underlying mechanism is elusive. Objective To explore the effect and mechanism of …

Estrogen deficiency is considered to be an important factor leading to cardiovascular
diseases (CVDs). Indeed, the prevalence of CVDs in postmenopausal women exceeds that …

Sex differences are evident in the pathophysiology of heart failure (HF). Progression of HF is
promoted by cardiac fibrosis and no fibrosis-specific therapies are currently available. The …

Cadmium is one of the most harmful elements to human health, and the health of
postmenopausal females is an important public health issue. However, the correlation …

Cardiac dysfunction/damage following trauma, shock, sepsis, and ischemia impacts clinical
outcomes. Acute inflammation and oxidative stress triggered by these injuries impair …

Background: Coronary artery calcificition (CAC) is a well-established predictor of
cardiovascular events (CVEs). We aimed to evaluate whether lung cancer screening …

Introduction The cardiovascular dysfunctions in postmenopausal diabetic women increase
relative to premenopausal women. In this study we evaluated protective effects of selective …

The way we view coronary artery disease in women has changed dramatically over the past
decades. From an initial perspective that coronary artery disease was a male disorder and …